Mayer SA, Bruder N, Citerio G, Defreyne L, et al. REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurosurg 2024 Aug 9:1-12. doi: 10.3171/2024.4.JNS232191.
PMID: 39126720